WHO ICTRP trial
Acupuncture for treatment of joint pain secondary to aromatase inhibitor therapy…
ACTRN12611000149965 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Recruiting
Key facts
| Trial ID | ACTRN12611000149965 |
|---|---|
| Public title | Acupuncture for treatment of joint pain secondary to aromatase inhibitor therapy in women with early breast cancer |
| Scientific title | Feasibility of use of acupuncture for treatment of arthralgia secondary to aromatase inhibitor therapy in women with early breast cancer |
| Primary sponsor | Royal Prince Alfred Hospital |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | Australia |
| Conditions | Arthralgia secondary to aromatase inhibitor;Breast Cancer; Arthralgia secondary to aromatase inhibitor Breast Cancer;Cancer - Breast;Musculoskeletal - Other muscular and skeletal disorders |
| Interventions | Acupuncture twice weekly for 6 weeks. The sites which will be used are L14, LI11, GB34, ST40, Du20, Shishencong and Baxie on Day 1(First Session) and GB21, ST36, TH5, SP6 and LIV3 on Day 2 (Second Session). In the treatment group the… |
| Registration date | Aug 2, 2011 |
| Target size | 30 |
| Secondary IDs | X09-0023 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: